FDA Comes Under Fire From Sen. Clinton Over Plan B Decision
This article was originally published in The Pink Sheet Daily
Executive Summary
The New York Democrat seeks a Senate Health Committee oversight hearing and General Accounting Office investigation as part of full review of FDA’s rejection of OTC status for the emergency contraceptive.